Side-by-side comparison of AI visibility scores, market position, and capabilities
Subscription management platform taken private at $1.7B by Silver Lake/GIC Oct 2024; $419.9M ARR at 103% NRR with 451 enterprise customers competing with Chargebee and Stripe Billing for subscription billing automation.
Zuora, Inc. is a Redwood City, California-based subscription management and billing platform — taken private in October 2024 in a $1.7 billion acquisition by Silver Lake and GIC (Singapore's sovereign wealth fund) at $10/share (formerly NYSE: ZUO) — providing SaaS companies, IoT manufacturers, media publishers, and enterprises transitioning to recurring revenue models with quote-to-cash automation, usage-based billing, revenue recognition compliance, and subscription analytics. At the time of acquisition, Zuora had $419.9 million in ARR (+6% year-over-year), 451 large enterprise customers, and a 103% net revenue retention rate — metrics that validated the subscription business management platform's unit economics for Silver Lake's private market value creation thesis.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.